Illumina slashes costs by $100 million after China bans its sequencers. The company lowers its 2025 EPS outlook and aims for ...

Illumina will seek to cut $100 million in expenses by the end of this fiscal year as it plans to deal with a loss of revenue ...

It is very early days for Illumina’s spatial technology, with a lot of unknowns. But two early users gave GEN a glimpse into the data quality. Neither researcher has handled the kit in-house ...

In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against the other large-cap stocks. The big and large-cap stocks have spearheaded the rally in the past ...

The Chinese government took its economic sanctions against San Diego-based Illumina a step further Tuesday by banning the gene-sequencing company from importing its machines to the country.

The automated system was compared to manual kits such as the QIAamp Circulating ... data quality was observed using 2x150bp sequencing on Illumina NextSeq550 instrument using a hybridization ...

Consumables, such as sequencing kits for specific genomes, are the main revenue driver with over 70% revenue contribution. We expect strong consumables growth as customers transition to Illumina ...

SHANGHAI, March 4 (Reuters) - China announced a ban on Tuesday on imports of genetic sequencers from U.S. medical equipment maker Illumina (ILMN.O), opens new tab ...

This is where a gravel kit comes in. Originally designed in the '60s to protect jetliners from the dangers of landing on unpaved surfaces, these modifications were a critical safety feature of ...

In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against the other large-cap stocks. The big and large-cap stocks have spearheaded the rally in the past two ...